Second Fund's investment, in Enemce Farma, SL

Mollet del Vallès, December 1st, 2012.


During the month of November, the Knowledge Capital Fund has made its second investment in the company Enemce Pharma with an initial contribution of € 5,500.

This contribution aims at developing a first proof of concept phase, which if successful will result in the development phase and subsequent investments.

Enemce Pharma is a classic drug discovery company created to develop a new drug candidate for the prevention of cardiovascular events.